Interview: Jeff Ditchfield

The interview with Jeff Ditchfield provides insight into the history and current landscape of medical cannabis use in the UK. As a long-standing advocate and caregiver, Jeff has played a key role in supporting patients through the development of medicinal cannabis products and the push for legal access. This article summarises key points from the interview, with a focus on the medical, legal, and practical aspects of using cannabis for health conditions.

Key takeaways

• Jeff Ditchfield has been involved in the medical cannabis movement in the UK for over 15 years, supporting patients through organisations like Bud Buddies UK.
• Bud Buddies UK has collected extensive feedback from patients, which has been used to improve the quality and effectiveness of cannabis-based treatments.
• The organisation produces laboratory-tested cannabinoid preparations to ensure consistency and safety, which is essential for medical use.
• Jeff is currently involved in advocacy efforts, including supporting the campaign for the right to home grow and supply within private membership clubs.

Evidence base

The use of cannabis for medical purposes is supported by a growing body of research, though the evidence remains mixed in terms of effectiveness and safety. Studies have shown that cannabis can help alleviate symptoms such as chronic pain, nausea, and muscle spasms in conditions like multiple sclerosis and epilepsy. However, the evidence is often limited by the legal status of cannabis in many countries, which has restricted large-scale clinical trials.

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates cannabis-based medicines, and some products have been approved for specific conditions. The National Institute for Health and Care Excellence (NICE) has also issued guidance on the use of cannabis-based products, highlighting their potential benefits but also noting the need for further research. The lack of standardised dosing and long-term safety data remains a significant challenge in the field. The role of patient feedback in the development of medical cannabis products is well documented.

Organisations like Bud Buddies UK have used patient reports to refine their formulations and improve outcomes. This approach highlights the importance of patient-centred care in the medical cannabis space. However, it is important to note that anecdotal evidence, while valuable, cannot replace rigorous clinical trials. The variability in cannabis composition and the lack of standardised dosing make it difficult to draw definitive conclusions about efficacy and safety.

As a result, medical professionals often rely on a combination of clinical guidelines, patient reports, and regulatory oversight to make informed decisions about cannabis use. In the UK, the legal status of cannabis remains complex. While cannabis-based medicines are available through the NHS for certain conditions, the cultivation and distribution of cannabis outside of approved medical products is illegal. This has led to a reliance on private organisations like Bud Buddies UK to provide access to patients who may not have other options.

However, the legal risks associated with these activities are significant, and patients should be aware of the potential consequences of using cannabis outside of legal frameworks. The UK government has shown interest in reforming cannabis laws, but as of now, the regulatory environment remains restrictive, limiting the availability of cannabis-based treatments for many patients.

What patients should know

Medical cannabis is not a one-size-fits-all solution. Its effectiveness can vary depending on the condition being treated, the method of administration, and the individual’s response to the product. Patients should be aware that while some studies suggest cannabis may help with symptoms like pain, nausea, and sleep disturbances, the evidence is not yet strong enough to recommend it as a first-line treatment for most conditions. It is also important to note that cannabis can have side effects, including dizziness, dry mouth, and changes in appetite, and long-term use may lead to dependency or other health issues.

Patients should also be cautious about the quality and safety of cannabis products. While some organisations, like Bud Buddies UK, provide laboratory-tested preparations, the market for cannabis products is largely unregulated. This means that the potency, purity, and consistency of products can vary widely, which can affect their safety and effectiveness. Patients should only use cannabis products that have been approved by regulatory bodies or prescribed by a healthcare professional. It is crucial for patients to discuss the use of cannabis with their clinician before starting any treatment.

A healthcare provider can help assess the potential benefits and risks, determine the appropriate dosage, and monitor for any adverse effects. Patients should also be aware of the legal implications of using cannabis, as it is illegal to cultivate or distribute cannabis outside of approved medical products in the UK. This means that while some patients may access cannabis through private organisations, they should be aware of the legal risks and the potential for criminal prosecution.

When to speak to a clinician

Patients should consult a clinician before starting any cannabis-based treatment, especially if they have a pre-existing medical condition or are taking other medications. A healthcare provider can help determine whether cannabis is a suitable option and guide patients on the appropriate method of administration and dosage. It is also important to discuss any potential interactions between cannabis and other medications, as cannabis can affect the metabolism of certain drugs.

Patients should seek medical advice if they experience any adverse effects from cannabis use, such as dizziness, confusion, or changes in mood. These symptoms may indicate an allergic reaction or an overdose, and prompt medical attention is essential. Additionally, patients should speak to a clinician if they are concerned about the legal status of cannabis use or if they are unsure about the safety of a particular product. Regular follow-up appointments can help monitor the effectiveness of treatment and make any necessary adjustments.

Questions to ask a clinician

• What are the potential benefits and risks of using cannabis for my condition?
• Is cannabis a suitable treatment option for me, or are there better alternatives?
• How should I take cannabis, and what is the appropriate dosage?
• Are there any interactions between cannabis and the medications I am currently taking?

Source trail